Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: BioMarin Pharmaceutical Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
BioMarin Pharmaceutical Inc. June 2, 202698.2%
-
Metagenomi Therapeutics Inc. June 10, 202572.4%
-
BioMarin Pharmaceutical Inc. May 20, 202598.5%
-
Seres Therapeutics Inc. April 10, 202563.1%
-
BioMarin Pharmaceutical Inc. May 21, 202496.4%
-
BioMarin Pharmaceutical Inc. May 23, 202395.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 2, 2026 | BioMarin Pharmaceutical Inc. | Grant or award | +7,490 | — | — |
| May 20, 2025 | BioMarin Pharmaceutical Inc. | Grant or award | +6,650 | — | — |
| May 21, 2024 | BioMarin Pharmaceutical Inc. | Grant or award | +4,720 | — | — |
| May 23, 2023 | BioMarin Pharmaceutical Inc. | Grant or award | +4,190 | — | — |
Questions about Willard H. Dere
What boards is Willard H. Dere on?
Willard H. Dere sits on the boards of BioMarin Pharmaceutical Inc., Metagenomi Therapeutics Inc. and Seres Therapeutics Inc.
How long has Willard H. Dere served on boards?
Our records show at least 10 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.